hsa-miR-27b-3p

ncRNA information

ncRNA name

hsa-miR-27b-3p

Specific or universal ncRNAs

Universal ncRNAs

Class

MicroRNA

Biomarker

No

Biomarker application

Upstream regulatory factors

Not available

Downstream target

PPARĪ³

Cancer information

Cancer name

Anaplastic Thyroid Cancer

Cancer site

Thyroid

Treatment information

Treatment type

Chemotherapy

Drug

Doxorubicin

Impact of wild-type ncRNA on chemotherapy resistance

Impact of knockdown of ncRNA on chemotherapy resistance

Down

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

Targeted inhibition of miR-27b can increase the sensitivity of SW1736/Dox and 8305C/Dox cells.

Tissue resource

human anaplastic thyroid carcinoma cell lines SW1736

human anaplastic thyroid carcinoma cell lines 8305C

Experiment

qRT-PCR,Western blot,Dual-luciferase reporter assay


Institute

the Shanghai Institute of Cell Biology, Chinese Academy of Sciences

Country

China

Continent

Asia